Results 1 to 10 of about 23 (22)
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O Imatinib é um inibidor do receptor tirosina-quinase que foi confirmada como exercendo um efeito inibidor sobre a atividade do receptor do PDGF, fator de crescimento plaquetário (PDGFRα e PDGFRβ).
Li-kun Ma +9 more
doaj +3 more sources
Imatinib atenua a fibrose miocárdica em associação com a inibição da atividade do PDGFRα
Arquivos Brasileiros de Cardiologia, 2012 FUNDAMENTO: O Imatinib é um inibidor do receptor tirosina-quinase que foi confirmada como exercendo um efeito inibidor sobre a atividade do receptor do PDGF, fator de crescimento plaquetário (PDGFRα e PDGFRβ).
Li-kun Ma +9 more
doaj
Some of the next articles are maybe not open access.
Eph receptors and ephrins in cancer progression
Nature Reviews Cancer, 2023Elena B Pasquale, Pasquale Elena B
exaly
Mechanisms of ephrin–Eph signalling in development, physiology and disease
Nature Reviews Molecular Cell Biology, 2016Artur Kania +2 more
exaly
Therapeutic targeting of EPH receptors and their ligands
Nature Reviews Drug Discovery, 2013Perry F Bartlett +2 more
exaly
Eph receptor signalling casts a wide net on cell behaviour
Nature Reviews Molecular Cell Biology, 2005Elena B Pasquale, Pasquale Elena B
exaly
The role of ephrins and Eph receptors in cancer
Cytokine and Growth Factor Reviews, 2004Patrick C, Ravi Salgia
exaly
The ephrins and Eph receptors in angiogenesis
Cytokine and Growth Factor Reviews, 2002Nikki Cheng, Jin Chen
exaly
Architecture of Eph receptor clusters
Proceedings of the National Academy of Sciences of the United States of America, 2010Juha P Himanen +2 more
exaly
Eph receptors and ephrins in cancer: bidirectional signalling and beyond
Nature Reviews Cancer, 2010Elena B Pasquale, Pasquale Elena B
exaly